Department of Microbiology and Immunology, Drexel University College of Medicine and Hepatitis B Foundation, Pennsylvania Biotechnology Center, Doylestown, PA, USA.
Cancer Biomark. 2010;9(1-6):375-83. doi: 10.3233/CBM-2011-0165.
Primary cancer of the liver, hepatocellular carcinoma (HCC), is an extremely deadly cancer, with very poor 5 year survivals, following diagnosis. The poor outcomes are believed to be due, in part, to the late times in which the cancers are usually first detected. Improved methods for early detection have thus become a top priority in the management of liver cancer. This Chapter reviews current methods of detection as well as leading new methods. Possible explanations as to why there are so many markers that are being discovered, but so few that make it to validation are discussed.
原发性肝癌(HCC)是一种极其致命的癌症,在诊断后 5 年的生存率非常低。不良预后的原因部分归因于癌症通常首次检测到的时间较晚。因此,改进早期检测方法已成为肝癌管理的重中之重。本章回顾了当前的检测方法以及领先的新方法。讨论了为什么发现了如此多的标志物,但只有少数标志物能够通过验证的可能原因。